🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New paper published in Cancer Treatment Reviews! What to consider after progression on CDK4/6i in HR+/HER2- mBC? Insights from a panel of Italian experts. Grateful for the opportunity to contribute to this work! 👉 Open access: doi.org/10.1016/j.ctrv…

Thanks to Matteo Lambertini, MD PhD for two amazing days in Genova for #YBO. Outstanding presentations 📚 Lots of friends 👨🏼‍🔬🧑‍🔬🧑‍🏫 Inspiring networking 🔗

Da oggi al 14 con AIOM Fondazione Aiom Fondazione AIRC per la ricerca sul cancro SIRM saremo al Porto Antico del COMUNE DI GENOVA per parlare di #prevenzione in oncologia in occasione dell'arrivo del Tour Vespucci Lucia Del Mastro Matteo Lambertini, MD PhD Carlo Genova Francesca Poggio Davide Soldato Andrea Boutros Università di Genova

Beautiful return to Porto Antico Genova of the #AmerigoVespucci after 2 years on Tour Vespucci world tour 🇮🇹🌍🏴󠁧󠁢󠁥󠁮󠁧󠁿 If you visit “the most beautiful ship in the world” stop by AIOM Fondazione AIRC per la ricerca sul cancro booth to talk about cancer and cancer prevention! Davide Soldato Andrea Boutros Marco Tagliamento

🚨New in Human Reproduction 🌟 Gonadotoxicity of immunotherapy and targeted agents in cancer patients and impact on subsequent pregnancies 🤰 🔗 Open access: academic.oup.com/humrep/advance… OncoAlert Luca Arecco, MD Matteo Lambertini, MD PhD

Such an important review! Thank you for summarizing the evidence.

We Are ALL OncoAlert 🚨 3⃣9⃣k of our Oncology Colleagues & Going STRONG ...and we are JUST Getting Started Entirely by Colleagues.....For Colleagues🌐 Our Gratitude for your support! Gil Morgan, MD #OncoAlertAF Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD, PhD Emre Yekedüz

New ESMO - Eur. Oncology germline testing recommendations in BC MGPT should include 7 genes with proven impact on BC-related mortality: BRCA1, BRCA2, PALB2, TP53 (in pts <40y), RAD51C, RAD51D and BRIP1. ATM and CHEK2 excluded due to low evidence on cancer-related mortality OncoAlert

📌 Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Clinical Insights✨ ascopubs.org/doi/10.1200/OP… 👉🏻 Why Omit SLNB? Balancing Benefits Versus Potential Harms 👉🏻 How Does SLNB Impact Radiation Therapy Decisions? 👉🏻 How Does SLNB Omission Impact Systemic

Onorata di intervenire a #ESCCardioOnco2025 La collaborazione tra diversi specialisti è un esempio concreto di quanto la multidisciplinarietà sia cruciale nella cura del cancro European Society of Cardiology AIOM #cardiooncology #collaborazione #oncologia #cardiologia #INSIEME

#INSIEME AIOM OncoAlert Ospedale San Martino Genova Università di Genova Francesca Poggio Marco Tagliamento Davide Soldato Carlo Genova Luca Arecco, MD Alessandra Gennari MD PhD Benedetta Conte Simone Nardin Marta Perachino Maria Grazia Razeti ChiaraMolinelli Diletta Favero

23ª Conferenza Nazionale AIOM: oncologi, associazioni pazienti e metodologi INSIEME per linee guida condivise e centrate sul paziente. Orgogliosi del contributo dell’oncologia genovese Università di Genova Ospedale San Martino Genova: linee guida carcinoma della prostata e preservazione della fertilità

Oncology Brothers Erika Hamilton, MD Elisabetta Bonzano MD, PhD Emre Yekedüz 4/ Luca Arecco, MD on new germline testing recommendations: x.com/Lucarecco/stat…

We’re excited to welcome the new and returning members of BIG’s Executive Board, starting 1 July 2025! Thank you to our outgoing members for their incredible dedication and leadership. Together, we continue advancing international breast cancer research. 💗

Looking forward to giving my contribution together with giants in the field of #BreastCancer…grateful for this opportunity! Università di Genova Breast International Group OncoAlert Europa Donna

Antonio Antonio Marra, oncologo della Divisione Nuovi Farmaci per Terapie Innovative a IEO, è tra i vincitori del Next Gen Clinician Scientist Grant, il prestigioso bando dell’ AIRC per la Ricerca sul Cancro. Uno dei giovani talenti italiani che il mondo ci invidia.

A newly published "review" article: 🔹️Fully funded and written with company support 🔹️Includes company employees as co-authors 🔹️Medical writing outsourced and paid for 🎗 Yet declares: "no conflicts of interest" 🫣And it's published in one of the highest-impact journals

Diversity in clinical trials: Maghreb pts have younger age and more aggressive BC but similar survival outcomes doi.org/10.1016/j.clbc… Chiara Dauccia Véronique Debien Soraia Lobo-Martins Elisa Agostinetto Luca Arecco, MD Diogo Martins Branco